| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Petrie MS et al. | Production of plasminogen activator inhibitor-1 (PAI-1) by endothelial cells: differential responses to calcitriol and paricalcitol. | 2004 | J. Thromb. Haemost. | pmid:15613047 |
| Dobrez DG et al. | Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings. | 2004 | Nephrol. Dial. Transplant. | pmid:15004264 |
| Durakovic C et al. | Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study. | 2004 | Br. J. Dermatol. | pmid:15270890 |
| Drüeke TB | Calcimimetics versus vitamin D: what are their relative roles? | 2004 | Blood Purif. | pmid:14732810 |
| Salusky IB | Are new vitamin D analogues in renal bone disease superior to calcitriol? | 2005 | Pediatr. Nephrol. | pmid:15690188 |
| Li H et al. | Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 | Chem. Res. Toxicol. | pmid:15962942 |
| Robinson DM and Scott LJ | Spotlight on paricalcitol in secondary hyperparathyroidism. | 2005 | Treat Endocrinol | pmid:15898824 |
| Koeffler HP et al. | Vitamin D(2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome. | 2005 | Leuk. Res. | pmid:16164982 |
| Kumagai T et al. | 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. | 2005 | Cancer Res. | pmid:15781666 |
| Robinson DM and Scott LJ | Paricalcitol: a review of its use in the management of secondary hyperparathyroidism. | 2005 | Drugs | pmid:15733015 |
Paricalcitol
Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.
Cross Reference
Introduction
To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Paricalcitol?
Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Paricalcitol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Paricalcitol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Paricalcitol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What genes are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.